Trial Profile
A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2014
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary arterial hypertension
- Focus Registrational; Therapeutic Use
- Acronyms PROWESS 15
- Sponsors Actelion Pharmaceuticals
- 29 Mar 2014 New trial record
- 24 Nov 2009
- 11 Sep 2009